An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Zhang, Xuewu, Gureasko, Jodi, Shen, Kui, Cole, Philip A., Kuriyan, John·2006·Cell

DOI 10.1016/j.cell.2006.05.013

Cited by (1,001)

Items 301–400 of 1,001

Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor
Erika Kovács, Rahul Das, Qi Wang, Timothy S. Collier, Aaron J. Cantor, Yongjian Huang, Kathryn Wong, Amar Mirza, Tiago F. Barros, Patricia Grob et al. · 2015 · Molecular and Cellular Biology
Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family
Stephen C. Artim, Jeannine M. Mendrola, Mark A. Lemmon · 2012 · Biochemical Journal
On the Origin of SERKs: Bioinformatics Analysis of the Somatic Embryogenesis Receptor Kinases
Marije aan den Toorn, Catherine Albrecht, Sacco C. de Vries · 2015 · Molecular Plant
Understanding cytokine and growth factor receptor activation mechanisms
Mariya Atanasova, Adrian Whitty · 2012 · Critical Reviews in Biochemistry and Molecular Biology
EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer
Sung Hee Choi, Jeannine M. Mendrola, Mark A. Lemmon · 2006 · Oncogene
Receptor tyrosine kinases: biological functions and anticancer targeted therapy
Nan Zhang, Yongsheng Li · 2023 · MedComm
Unmasking Determinants of Specificity in the Human Kinome
Pau Creixell, Antonio Palmeri, Chad J. Miller, Hua Jane Lou, Cristina Costa Santini, Morten Nielsen, Benjamin E. Turk, Rune Linding · 2015 · Cell
Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors
Oliver D. Hantschel · 2014 · ACS Chemical Biology
The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes
Hongmei Wang, Yunfei Xu, Shanglei Ning, Duxiao Yang, Yi Li, Yu-Jie Du, Fan Yang, Ya Zhang, Nan Liang, Wei Yao et al. · 2014 · Cell Research
Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: Insights from multiscale molecular dynamics simulations
Khairul Bariyyah Abd Halim, Heidi Koldsø, Mark S.P. Sansom · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
Crystal structure of the plexin A3 intracellular region reveals an autoinhibited conformation through active site sequestration
Huawei He, Taehong Yang, Jonathan R. Terman, Xuewu Zhang · 2009 · Proceedings of the National Academy of Sciences
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase
Jörg O. Schulze, Giorgio Saladino, Katrien Busschots, Sonja Neimanis, Evelyn Süß, Dalibor Odadzic, Stefan Zeuzem, Valérie Hindie, Amanda Katherina Herbrand, María‐Natalia Lisa et al. · 2016 · Cell chemical biology
The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding
Jennifer L. Macdonald-Obermann, LINDA JOY PIKE · 2009 · Journal of Biological Chemistry
Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors
Simone Filosto, Cathleen R. Becker, Tzipora Goldkorn · 2012 · Molecular Cancer Therapeutics
Single-Molecule Imaging and Fluorescence Lifetime Imaging Microscopy Show Different Structures for High- and Low-Affinity Epidermal Growth Factor Receptors in A431 Cells
Stephen E. D. Webb, Selene K. Roberts, Sarah R. Needham, Christopher J. Tynan, Daniel J. Rolfe, Martyn Winn, David T. Clarke, Roger Barraclough, Marisa L. Martin-Fernandez · 2007 · Biophysical Journal
Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells
Mary E. Irwin, Natacha Bohin, Julie L. Boerner · 2011 · Cancer Biology & Therapy
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments
F. Barros, Desmond George Powe, Ian Ogilvie Ellis, Andrew R. Green · 2010 · Histopathology
EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms
Bettina van Lengerich, Christopher Agnew, Elias M. Puchner, Bo Huang, Natalia Jura · 2017 · Proceedings of the National Academy of Sciences
ErbB signaling in cardiac development and disease
Pablo Sanchez-Soria, Todd D. Camenisch · 2010 · Seminars in Cell and Developmental Biology
Lining the pockets of kinases and phosphatases
Matthew G. Gold, David Barford, David Komander · 2006 · Current Opinion in Structural Biology
The insulin and IGF1 receptor kinase domains are functional dimers in the activated state
Maria Zulema Cabail, Shiqing Li, Eric Lemmon, Mark E. Bowen, Stevan R. Hubbard, W. Todd Miller · 2015 · Nature Communications
Predominance of activated EGFR higher-order oligomers on the cell surface
Andrew H. A. Clayton, Suzanne Gaye Orchard, Edouard Collins Nice, Richard G. Posner, Antony Wilks Burgess · 2008 · Growth Factors
Mechanisms for Kinase-mediated Dimerization of the Epidermal Growth Factor Receptor
Chafen Lu, Li-Zhi Mi, Thomas Schürpf, Thomas Walz, Timothy A. Springer · 2012 · Journal of Biological Chemistry
Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
Rania S. M. Ismail, Nasser S. M. Ismail, Sahar Abuserii, Dalal A. Abou El Ella · 2016 · Future Journal of Pharmaceutical Sciences
Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers
Ya-Fei Du, Feride Karatekin, Wendy Kehan Wang, Wanjin Hong, T. K. B. Gandhi · 2025 · Pharmacological Reviews
TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-κB-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling
Miki Nishimura, Myoung-Sook Shin, Pattama Singhirunnusorn, Shunsuke Suzuki, Miho Kawanishi, Keiichi Koizumi, Ikuo Saiki, Hiroaki Sakurai · 2009 · Molecular and Cellular Biology
EGFR-Targeted Photodynamic Therapy
Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, Alberto Danielli, Matteo Calvaresi · 2022 · Pharmaceutics
Synthetic approach to homodimeric protein–polymer conjugates
Lei Tao, Catherine S. Kaddis, Rachel R. Ogorzalek Loo, Gregory N. Grover, Joseph A. Loo, Heather D. Maynard · 2009 · Chemical Communications
Reconstitution and characterization of eukaryotic N6-threonylcarbamoylation of tRNA using a minimal enzyme system
Leo C. K. Wan, Daniel Y.L. Mao, Dante Neculai, Jonathan G. Strecker, David Chiovitti, Igor V. Kurinov, Gennadiy I. Poda, Neroshan Thevakumaran, Fang Yuan, Rachel K. Szilard et al. · 2013 · Nucleic Acids Research
Sequence and Structure Signatures of Cancer Mutation Hotspots in Protein Kinases
Anshuman Dixit, Lin Yi, Ragul Gowthaman, Ali Torkamani, Nicholas J. Schork, Gennady M. Verkhivker · 2009 · PLoS ONE
Computational Modeling of Allosteric Communication Reveals Organizing Principles of Mutation-Induced Signaling in ABL and EGFR Kinases
Anshuman Dixit, Gennady M. Verkhivker · 2011 · PLoS Computational Biology
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon, Mi-Sun Kim, Hyun Suk Jung, Youngmi Kim, Dooil Jeoung · 2019 · Cancers
Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family
Anton S. Arkhipov, Yibing Shan, Eric T. Kim, Ron O. Dror, David Elliot Shaw · 2013 · eLife
Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations
Anja Bremm, Axel Karl Walch, Margit Fuchs, Jörg Mages, Justus Duyster, Gisela Keller, Christine Hermannstädter, Karl‐Friedrich Becker, Sandra Rauser, Rupert Langer et al. · 2008 · Cancer Research
EGFR Trafficking in Physiology and Cancer
Giusi Caldieri, Maria Grazia Malabarba, Pier Paolo Di Fiore, Sara Sigismund · 2018 · Progress in molecular and subcellular biology
Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores
Gergő Gógl, Alexandr P. Kornev, Attila Reményi, Susan Serota Taylor · 2019 · Trends in Biochemical Sciences
Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells
Fabrizio Capuani, Alexia Conte, Elisabetta Argenzio, Luca Marchetti, Corrado Priami, Simona Polo, Pier Paolo Di Fiore, Sara Sigismund, Andrea Ciliberto · 2015 · Nature Communications
Receptor tyrosine kinases with intracellular pseudokinase domains
Jeannine M. Mendrola, Fumin Shi, Jin H. Park, Mark A. Lemmon · 2013 · Biochemical Society Transactions
Proteus in the World of Proteins: Conformational Changes in Protein Kinases
Matthias Rabiller, Matthäus Getlik, Sabine Klüter, André Richters, Sandra Tückmantel, Jeffrey R. Simard, Daniel Rauh · 2010 · Archiv der Pharmazie
The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity
Sergio Anastasi, Maria Francesca Baietti, Yuri Frosi, Stefano Alemà, Oreste Segatto · 2007 · Oncogene
Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases
Nicholas Endres, Tiago F. Barros, Aaron J. Cantor, John Kuriyan · 2014 · Trends in Biochemical Sciences
Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041
Jiefei Tong, Paul P. Taylor, Scott M. Peterman, Amol Prakash, Michael F. Moran · 2009 · Molecular & Cellular Proteomics
Pertuzumab: Optimizing HER2 Blockade
Otto Metzger, Eric P. Winer, Ian E. Krop · 2013 · Clinical Cancer Research
Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans
Iván Plaza-Menacho, Karin Barnouin, Kerry Marie Goodman, R.J. Martinez-Torres, Annabel Borg, Judith Murray‐Rust, Stéphane Mouilleron, Phillip P. Knowles, Neil Q. McDonald · 2014 · Molecular Cell
Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins
Katharine A. White, Diego Garrido Ruiz, Zachary A. Szpiech, Nicolas B. Strauli, Ryan D. Hernandez, Matthew P. Jacobson, Diane L. Barber · 2017 · Science Signaling
Molecular Oncology of Breast Cancer
Himanshu N. Joshi, Michael F. Press · 2017 · Elsevier eBooks
RETRACTED: Cytohesins Are Cytoplasmic ErbB Receptor Activators
Anke Bill, Anton Schmitz, Barbara Albertoni, Jinna Song, Lukas Carl Heukamp, David Walrafen, Franziska Thorwirth, Peter J. Verveer, Sebastian Zimmer, Lisa Meffert et al. · 2010 · Cell · Retracted
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily
Valentina Gandin, Alessandro Ferrarese, Martina Dalla Via, Cristina Marzano, Adriana Chilin, Giovanni Marzaro · 2015 · Scientific Reports
A critical evaluation of protein kinase regulation by activation loop autophosphorylation
Ronja Reinhardt, Thomas A. Leonard · 2023 · eLife
Networks for the allosteric control of protein kinases
Zhengshuang Shi, Katheryn A. Resing, Natalie G. Ahn · 2006 · Current Opinion in Structural Biology
Quantitative Prediction of Fold Resistance for Inhibitors of EGFR
Trent E. Balius, Robert C. Rizzo · 2009 · Biochemistry
Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling
Qian Zhang, Euisun Park, Kian Kani, Ralf Landgraf · 2012 · Proceedings of the National Academy of Sciences
Structural insight into the activation of plant receptor kinases
Zhifu Han, Yadong Sun, Jijie Chai · 2014 · Current Opinion in Plant Biology
More from less – bottom-up reconstitution of cell biology
Kristina A. Ganzinger, Petra Schwille · 2019 · Journal of Cell Science
Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy
Yuan Liang, Tiehua Zhang, Jie Zhang · 2020 · Pharmacological Research
Activating ERBB4 mutations in non-small cell lung cancer
Kari J. Kurppa, Konstantin A. Denessiouk, Mark S. Johnson, Klaus Elenius · 2015 · Oncogene
Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants
Leo Kei Iwai, Leo S. Payne, Maciej T. Luczynski, Francis Chang, Huifang Xu, Ryan W. Clinton, Angela Paul, Edward A. Esposito, Scott Gridley, Birgit Leitinger et al. · 2013 · Biochemical Journal
Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
Estefanía Carrasco‐García, Miguel Saceda, Isabel Martínez-Lacaci · 2014 · Cells
Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib
Yan Xu, Hongyu Liu, Jun Chen, Qinghua Zhou · 2010 · Cancer Biology & Therapy
The ErbB kinase domain: Structural perspectives into kinase activation and inhibition
Ron Bose, Xuewu Zhang · 2008 · Experimental Cell Research
Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045
Peng Zhao, Ming-Yu Yao, Sujie Zhu, Jiyun Chen, Cai‐Hong Yun · 2018 · Biochemical and Biophysical Research Communications
Allosteric Regulation at the Crossroads of New Technologies: Multiscale Modeling, Networks, and Machine Learning
Verkhivker, Gennady M., Agajanian, Steve, Hu, Guang, Tao, Peng · 2020 · Frontiers in Molecular Biosciences
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface
Jeroen Claus, Gargi Surendra Patel, Flavia Autore, Audrey Colomba, Gregory E. Weitsman, Tanya N. Soliman, Selene K. Roberts, Laura C. Zanetti-Domingues, Michael Hirsch, Francesca Collu et al. · 2018 · eLife
The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site
Gladys de Leon Boenig, Krista K. Bowman, Jianwen A. Feng, Terry D. Crawford, Christine Everett, Yvonne Franke, Angela Oh, Mark S. Stanley, Steven T. Staben, Melissa A. Starovasnik et al. · 2012 · Structure
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family
Sean P. Kennedy, Jordan F. Hastings, Jeremy Z. R. Han, David R. Croucher · 2016 · Frontiers in Cell and Developmental Biology
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia
Laurel E. Black, Jody Fromm Longo, Steven Lewis Carroll · 2019 · American Journal Of Pathology
Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors
Hao Lei, Shu Fan, Hao Zhang, Yan-Jie Liu, Yuan‐Yuan Hei, Junjie Zhang, Aqun Zheng, Minhang Xin, San‐Qi Zhang · 2019 · European Journal of Medicinal Chemistry
Stealth carriers for low-resolution structure determination of membrane proteins in solution
Selma Maric, Nicholas Skar‐Gislinge, Søren Roi Midtgaard, Mikkel B. Thygesen, Jürgen Schiller, Henrich Frielinghaus, Martine Moulin, Michael Haertlein, V. Trevor Forsyth, Thomas Günther Pomorski et al. · 2014 · Acta Crystallographica Section D Biological Crystallography
Exploring higher-order EGFR oligomerisation and phosphorylation—a combined experimental and theoretical approach
Noga Kozer, Dipak Barua, Suzanne Gaye Orchard, Eduoard C. Nice, Antony Wilks Burgess, William S. Hlavacek, Andrew H. A. Clayton · 2013 · Molecular BioSystems
Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases
Christine Yueh, Justin Rettenmaier, Bing Xia, David R. Hall, Andrey Evgen'evich Alekseenko, Kathryn A. Porter, Krister J. Barkovich, György Miklós Keserű, Adrian Whitty, James A. Wells et al. · 2019 · Journal of Medicinal Chemistry
Current Approaches in NSCLC Targeting K-RAS and EGFR
Veronica Aran, Jasminka Omerović · 2019 · International Journal of Molecular Sciences
Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
Samantha I. Liang, Bettina van Lengerich, Kelsie Eichel, Minkwon Cha, David M. Patterson, Tae‐Young Yoon, Mark von Zastrow, Natalia Jura, Zev J. Gartner · 2018 · Cell Reports
Transmembrane helix-helix interactions involved in ErbB receptor signaling
Florian Cymer, Dirk Schneider · 2010 · Cell Adhesion & Migration
Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
Zhi Li, Milica Gakovic, Josiane Ragimbeau, Maija‐Leena Eloranta, Lars Rönnblom, Frédérique Michel, Sandra Pellegrini · 2013 · The Journal of Immunology
Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR
Chung, Kuei-Pin, Wu, Shang-Gin, Wu, Jenn-Yu, Yang, James Chih-Hsin, Yu, Chong-Jen, Wei, Pin-Fei, Shih, Jin-Yuan, Yang, Pan-Chyr · 2012 · Clinical Cancer Research
EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy
Cristina Zahonero, Pilar Sánchez‐Gómez · 2014 · Cellular and Molecular Life Sciences
Lung Injury and Cancer
Tzipora Goldkorn, Simone Filosto · 2010 · American Journal of Respiratory Cell and Molecular Biology
Bipartite Tetracysteine Display Reveals Allosteric Control of Ligand-Specific EGFR Activation
Rebecca A. Scheck, Melissa A. Lowder, Jacob Appelbaum, Alanna Schepartz · 2012 · ACS Chemical Biology
IL-1 and EGF regulate expression of genes important in inflammation and cancer
Aneta Kasza · 2013 · Cytokine
Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin-Coated Pits
Jenny Ibach, Yvonne Radon, Márton Gelléri, Michael H. Sonntag, Luc Brunsveld, Philippe I. H. Bastiaens, Peter J. Verveer · 2015 · PLoS ONE
Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies
Zhiwei Yu, Titus J. Boggon, Susumu S. Kobayashi, Cheng Jin, Patrick C. Ma, Afshin Dowlati, Jeffrey A. Kern, Daniel Geoffrey Tenen, Balázs Halmos · 2007 · Cancer Research
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
Lucas, Lauren M., Dwivedi, Vipasha, Senfeld, Jared I., Cullum, Richard L., Mill, Christopher P., Piazza, J. Tyler, Bryant, Ianthe N., Cook, Laura J., Miller, S. Tyler, Lott, James H. et al. · 2022 · Pharmacological Reviews
EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling
Martin E. Baumdick, Yannick Brüggemann, Malte Schmick, Georgia Xouri, Ola Sabet, Lloyd Davis, Jason W. Chin, Philippe I. H. Bastiaens · 2015 · eLife
Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)
Alexandru Șandor, Ioana A. Ionuţ, Gabriel Marc, Ilioara Oniga, Dan Tudor Eniu, Ovidiu Oniga · 2023 · Pharmaceuticals
HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks
Ralf Landgraf · 2007 · Breast Cancer Research
Hierarchical Modeling of Activation Mechanisms in the ABL and EGFR Kinase Domains: Thermodynamic and Mechanistic Catalysts of Kinase Activation by Cancer Mutations
Anshuman Dixit, Gennady M. Verkhivker · 2009 · PLoS Computational Biology
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism
Gur Pines, Paul H. Huang, Yaara Zwang, Forest M. White, Yosef Yarden · 2010 · Oncogene
Exploiting Atropisomerism to Increase the Target Selectivity of Kinase Inhibitors
Davis E. Smith, Isaac Marquez, Melissa E. Lokensgard, Arnold L. Rheingold, David Hecht, Jeffrey L. Gustafson · 2015 · Angewandte Chemie International Edition
Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib
Tona M. Gilmer, LouAnn Cable, Krystal J. Alligood, David W. Rusnak, Glenn M. Spehar, Kathleen T. Gallagher, Ermias Woldu, H. Luke Carter, Anne T. Truesdale, Lisa M. Shewchuk et al. · 2008 · Cancer Research
Development of small molecules targeting the pseudokinase Her3
Sang Min Lim, Ting Xie, Kenneth D. Westover, Scott B. Ficarro, Hyun Seop Tae, Deepak Gurbani, Taebo Sim, Jarrod A. Marto, Pasi Antero Janne, Craig M. Crews et al. · 2015 · Bioorganic & Medicinal Chemistry Letters
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
Jennifer L. Macdonald-Obermann, David R Piwnica-Worms, LINDA JOY PIKE · 2011 · Proceedings of the National Academy of Sciences
A crystallographic snapshot of tyrosine trans -phosphorylation in action
Huaibin Chen, Chong‐Feng Xu, Jinghong Ma, Anna V. Eliseenkova, Wanqing Li, Pamela M. Pollock, Nelly Pitteloud, W. Todd Miller, Thomas A. Neubert, Moosa Mohammadi · 2008 · Proceedings of the National Academy of Sciences
HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions
Pavel E. Bragin, Konstantin S. Mineev, Olga V. Bocharova, Pavel E. Volynsky, Eduard Valeryevich Bocharov, Alexander S. Arseniev · 2015 · Journal of Molecular Biology
HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models
Dongsheng Wang, Guoqing Qian, Hongzheng Zhang, Kelly R. Magliocca, Sreenivas Nannapaneni, A.R.M. Ruhul Amin, Michael Rossi, Mihir R. Patel, Mark W. El‐Deiry, Jeffery Trad Wadsworth et al. · 2016 · Clinical Cancer Research
Allosteric Communication across the Native and Mutated KIT Receptor Tyrosine Kinase
Élodie Laine, Christian Auclair, Luba Tchertanov · 2012 · PLoS Computational Biology
Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors
David E. Heppner, Marcel Günther, Florian Wittlinger, Stefan Laufer, Michael J. Eck · 2020 · Journal of Medicinal Chemistry
Control of cell metabolism by the epidermal growth factor receptor
Laura A. Orofiamma, Dafne Vural, Costin N. Antonescu · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1
Victoria Prieto-Echagüe, Azad L. Gucwa, Barbara P. Craddock, Deborah A. Brown, W. Todd Miller · 2010 · Journal of Biological Chemistry
Groundbreaking Anticancer Activity of Highly Diversified Oxadiazole Scaffolds
Alessandra Benassi, Filippo Doria, Valentina Pirota · 2020 · International Journal of Molecular Sciences
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
Zhenfang Du, Benjamin P. Brown, Soyeon Kim, Donna C. Ferguson, Dean C. Pavlick, Gowtham Jayakumaran, Ryma Benayed, Jean‐Nicolas Gallant, Yunkai Zhang, Yingjun Yan et al. · 2021 · Nature Communications